SCHEMBL20049065

SCHEMBL20049065

CC(C)(C)c1cc(F)c2ncsc2c1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.33
ALOX5AP P20292 1/20 0.33
TRPV1 Q8NER1 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23408299 0.79 RIPK1 (0.33) TRPV1
SCHEMBL24345433 0.76 KMT2A (0.40) TRPV1
SCHEMBL15715213 0.76 HSD17B10 (0.32) IRAK4
SCHEMBL22142676 0.75 RAB9A (0.42)
SCHEMBL15688867 0.72 IRAK4 (0.30) IRAK4
SCHEMBL18876080 0.71 ALOX5AP (0.33) ALOX5AP
SCHEMBL17132580 0.71 IRAK4 (0.33) IRAK4
SCHEMBL19435503 0.71 TAAR1 (0.38)
SCHEMBL25079008 0.71 P4HB (0.32)
SCHEMBL14093000 0.70 ALDH1A1 (0.37) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed